| Published Version Download ( PDF | 2MB) | License: Creative Commons Attribution 4.0 |
Short-chain carnitines in adolescent major depressive disorder: Associations and biomarker potential
Niebler, Maximilian, Jarvers, Irina
, Brunner, Romuald
and Kandsperger, Stephanie
(2025)
Short-chain carnitines in adolescent major depressive disorder: Associations and biomarker potential.
Journal of Affective Disorders 390, p. 119832.
Date of publication of this fulltext: 16 Jul 2025 06:33
Article
DOI to cite this document: 10.5283/epub.77164
Abstract
Background A growing body of evidence suggests altered short-chain carnitine biology in mental health, notably significantly reduced serum levels of L-Acetyl-carnitine (LAC) in adults with major depressive disorder (MDD). Building on these findings, our biomarker study aimed to investigate potential MDD-associated disruptions in short-chain carnitines within juvenile cohorts. Methods In a ...
Background
A growing body of evidence suggests altered short-chain carnitine biology in mental health, notably significantly reduced serum levels of L-Acetyl-carnitine (LAC) in adults with major depressive disorder (MDD). Building on these findings, our biomarker study aimed to investigate potential MDD-associated disruptions in short-chain carnitines within juvenile cohorts.
Methods
In a cross-sectional analysis with between-group comparison we contrasted a cohort of adolescents with major depressive disorder (n = 38) with healthy controls (n = 38) by assessing peripheral blood levels of free l-carnitine (FC), LAC as well as the LAC/FC ratio and studied associations with psychometrically assessed clinical characteristics. To validate our cohort allocation and thus to corroborate the MDD related specification of our carnitine associated findings by replicating existing evidence towards specific altered endocrine parameters in adolescent MDD, we furthermore obtained morning cortisol, adrenocorticotropin (ACTH) and the cortisol/ACTH ratio.
Results
No significant inter-cohort differences were observed in FC or LAC-levels, but the LAC/FC ratio was significantly elevated in adolescents with depressive disorder (M(HC) = 0.39, SE = 0.02; M(MDD) = 0.47, SE = 0.02; Cohen's d = 0.80; p < 0.001). After controlling for confounders, in linear regression models, MDD cohort assignment emerged as a significant predictor of an elevated LAC/FC ratio (β = 0.432; p = 0.046; corr. R2 = 0.108), as well as reduced FC levels (β = −0.225; p = 0.049; corr. R2 = 0.120). Binominal regression analyses further identified the LAC/FC ratio (B = 7.432; p = 0.010; corr. R2 = 0.381) as a predictive marker for MDD cohort assignment. Overall, the significant alteration in the LAC/FC ratio reinforces the overarching hypothesis of altered carnitine biology in both adolescent and adult individuals with MDD. Whether adolescent MDD represents a partially aberrant molecular pathophysiology compared to adults, or instead reflects an underdeveloped molecular phenotype differentiation, remains an open question for further research.
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Journal of Affective Disorders | ||||
| Publisher: | Elsevier | ||||
|---|---|---|---|---|---|
| Open Access Type: | DEAL (Elsevier) | ||||
| Volume: | 390 | ||||
| Page Range: | p. 119832 | ||||
| Date | 6 July 2025 | ||||
| Institutions | Medicine > Lehrstuhl für Kinder- und Jugendpsychiatrie | ||||
| Identification Number |
| ||||
| Keywords | Major depressive disorder, Adolescents, Biomarkers, L-acetyl-carnitine, HPA-axis | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| URN of the UB Regensburg | urn:nbn:de:bvb:355-epub-771641 | ||||
| Item ID | 77164 |
Download Statistics
Download Statistics